Table 3.

 Sensitivity analysis: predicted outcomes and resource use over 10 years, per 1000 women treated if perfect compliance with recommendations is assumed

Recommended strategy	Cytology only follow-up	HPV test of cure—sentinel sites protocol	HPV test of cure—extended follow-up protocol
Health outcomes
Residual underlying cases of CIN3+ at 10 years	6.3	11.9	11.5
Residual underlying cases of CIN3+ averted compared with current practice	—	−5.6 (additional cases)	−5.1 (additional cases)
Costs
Discounted at 3.5% per year	£521 634	£388 108	£483 256

CIN=cervical intraepithelial neoplasia; HPV=human papillomavirus.